Abundant evidence now is available that free radicals are produced in excess when myocardium is reperfused following an episode of ischemia and that free radicals can injure myocytes and endothelial cells. Free radicals may contribute to either reversible or irreversible manifestations of cell injury from ischemia and reperfusion. Several investigators have observed that post-ischemic contractile dysfunction (myocardial stunning) can be attenuated by a variety of anti-free radical therapies, and there seems to be general agreement that free radical injury contributes to stunning. Whether free radicals are an important cause oflethal myocyte injury ("lethal reperfusion injury") remains controversial. Using similar interventions and animal models, both positive and negative results have been reported from a growing number of studies done to test the effect of anti-free radical therapies on infarct size. Proposed explanations include differences in: 1) dose of drug and onset or duration of treatment, 2) duration of occlusion or reperfusion, 3) methods of measuring infarct size or area at risk, and 4) failure of some studies to control for baseline variation in the major determinants of infarct size, e.g., collateral blood flow. At present, none of these explanations seems sufficient to resolve the question.
INTRODUCTION

Reversible and Irreversible Ischemic Injury
Myocardial ischemia ofsufficient severity and duration results in death of the affected myocytes (myocardial infarction). However, ischemic myocytes first enter a phase ofreversible injury, defined by the fact that timely reperfusion results in the survival ofmyocytes otherwise destined to die (37) . With increasing duration of ischemia, an increasing number ofmyocytes within the vascular area at risk die despite reperfusion. These myocytes are said to have entered a phase of irreversible injury because they undergo necrosis even though the initial cause ofinjury has been removed (37) . In the anesthetized canine model ofmyocardial infarction, irreversibility occurs as early as 20 min in the subendocardial zone. Conversely, reperfusion as late as three hours after the onset of ischemia still salvages some of the less severely ischemic myocytes in the subepicardial zone (61) .
Although reperfusion of reversibly injured cells prevents their demise (by definition), it is now widely known that such cells require time to recover structurally, metabolically, and functionally (36, 60) . Myocardium injured by as little as 5-15 min of ischemia may not recover normal contractility for hours or days after the event and is said to have been "stunned" (13) .
Nonlethal and Lethal Reperfusion Injury
In recent years, it has been proposed that reversible and/or irreversible manifestations ofinjury following a temporary episode of ischemia may not be caused directly by the state ofcellular affairs existing immediately prior to the moment of reperfusion, but may result from some deleterious aspect of re-perfusion, per se. This hypothetical concept is termed "reperfusion injury." Rosenkranz and Buckberg (67) have provided a general definition to this term: "Reperfusion injury refers to those [presumably detrimental] metabolic, functional and structural consequences of restoring coronary flow ... that can be avoided or reversed by modification of the conditions of reperfusion." Buckberg's group has studied reperfusion in the surgical setting of global myocardial ischemia during cardiopulmonary bypass, followed by reperfusion. However, their definition can be applied to regional myocardial ischemia as well.
In actual practice, the term "reperfusion injury" is used in diverse experimental or clinical settings and takes on one or another specific definition (Table I), depending on the context to which it is applied. For example, the reversible post-ischemic contractile dysfunction (stunning) observed in experimental studies, or in patients following cardiac surgery, may be a form of "reperfusion injury." Reperfusion arrhythmias also are considered by some investigators (4, 29) to be a form of reperfusion injury, although it is not clear to what extent such arrhythmias are due to actual reperfusion injury as opposed to heterogeneity in the rate of cellular recovery. In other circumstances, "reperfusion injury" has been used to refer to reversible or irreversible manifestations of microvascular injury (vs myocyte injury), which mayor may not cause additional myocyte injury.
In the setting of myocardial infarction, where an important therapeutic goal is to limit myocardial infarct size by reperfusion, with or without adjuvant pharmacologic therapy, "reperfusion injury" refers to the untoward death of myocytes which were still viable at the initiation ofreperfusion. We term this hypothetical consequence of reperfusion "lethal reperfusion injury." Accelerated cellular disintegration, which is manifest as contraction band necrosis, is the morphological hallmark of myocyte death in the setting of continuous or restored oxidative metabolism. Contraction band necrosis is viewed by some as evidence of lethal reperfusion injury; however, such is not necessarily the case because there is evidence that the myocytes which develop contraction band necrosis are, in fact, "dead" prior to the onset of reperfusion (33, 34) .
Finally, "reperfusion injury" could refer to weakening ofa myocardial infarct or an adverse effect on infarct repair which hypothetically could be caused by a deleterious effect of reperfusion, independent of any effect of reperfusion on myocardial infarct size, per se.
The pathogenesis of each of the aforementioned aspects ofmyocardial injury may be different. Thus,
Post-ischemic contractile dysfunction or metabolic abnormalities Reperfusion arrhythmias Post-ischemic microvascular obstruction or compression leading to reduced reperfusion or failed reperfusion (no-reflew phenomenon) Death of myocytes which still were viable at the initiation of reperfusion, i.e., "lethal reperfusion injury" Accelerated cellular disintegration (contraction band necrosis) Weakening of myocardial infarct or scar by a deleterious aspect of rcperfusion, e.g., hemorrhage
(See text for explanation.)
if "reperfusion injury" exacerbates post-ischemic contractile dysfunction (stunning) of viable myocytes, this does not necessarily imply that "reperfusion injury" kills myocytes, or vice versa. Moreover, the mechanism of"reperfusion injury" might not be the same in both circumstances. Thus, evidence favoring the existence of"reperfusion injury" by one definition does not provide evidence for the existence of "reperfusion injury" by another definition.
ROLE OF FREE RADICALS IN MYOCARDIAL STUNNING
Among the metabolic, structural, and functional manifestations of reversible cell injury, post-ischemic contractile dysfunction (stunning) has evoked considerable research interest. Contractile dysfunction may persist in viable myocardium for hours or days after a brief period of ischemic injury ( Fig. I ) (30, 82) .
A number of possible mechanisms of myocardial stunning have been proposed and are outlined in Table II . In general terms, these include reduced availability of ATP at the myofibril, injury of the contractile apparatus, per se, or alterations in calcium homeostasis (32, 42) . ATP availability at the myofibril could be limited by depletion of the adenine nucleotide pool (11, 60, 76) , reduced ATP production, e.g., by persistent ischemia or mitochondrial injury, or by impaired transport via the CP (creatine phosphate) shuttle. Altered calcium homeostasis could be due to altered sympathetic tone (9) , or to damage to the sarcolemma, or sarcoplasmic reticulum (41) , or to altered myofibrillar Ca sensitivity (86) . Although the slow functional recovery is paralleled by a slow recovery of total ATP content, the preponderance of evidence now suggests that ATP production is not limiting (23, 31) . In addition, there is substantial evidence that the mechanism ofstunning is some defect in calcium homeostasis (32, 42) .
The underlying cause of injury resulting in stunning also has not been defined precisely. However, segment length)/diastolic length] was measured using ultrasonic crystals implanted in the ischemic myocardium and is expressed as a percent of pre-occlusion shortening. Thus, the degree of shortening before ischemia is defined as 100%. During the ischemic episode, systolic contraction was replaced by systolic bulging (negative shortening). In control dogs, there was a very transient return of contractile function, after which there was persistent dysfunction, with no systolic shortening throughout the 2-hr period of measurement. Other investigators have observed that recovery to normal contractile function may require several days. Post-ischemic contractile shortening was substantially improved, i.e., stunning was attenuated, when dogs were pretreated with SOD and catalase. These results are similar to results from several other laboratories, using various anti-free radical therapies. ** = p < 0.0 I for control vs treated groups. Data are from the work of Murry et al (50) .
there is strong evidence that free radical injury may in some way contribute to stunning (6, 7, 17, 27, 52, 58) . A unifying hypothesis, combining evidence for free radical injury and defective calcium ho- meostasis, is that free radicals may damage a component of the calcium transport mechanisms in either the sarcolemma or sarcoplasmic reticulum.
LETHAL REPERFUSION INJURY
The hypothesis of "lethal reperfusion injury" is illustrated in Fig. 2 . It now is generally recognized that, unless there is very substantial collateral blood flow, the failure to reperfuse an occluded coronary artery will result in infarction of much of the occluded vascular bed at risk. It also is accepted that reperfusion, if done sufficiently soon, can salvage myocardium, especially in the subepicardial zone of the ischemic region (61) . Of the myocytes which cannot be salvaged by reperfusion, some may have been irreparably damaged by the ischemic injury. However, it has been hypothesized that some my- emic injury. If so, it follows that reperfusion plus adjuvant therapy to prevent reperfusion injury would salvage this tissue and result in smaller myocardial infarcts than reperfusion alone.
The concept of lethal reperfusion injury is extraordinarily important from the standpoint of designing therapy for myocardial infarction. In order to limit the extent ofischemic injury, the therapeutic goal must be to develop the means to slow immediately the course of injury, while the tissue is ischemic, pending reperfusion at the earliest possible moment. Iflethal reperfusion injury exists, the therapeutic possibilities are expanded to include possible adjunctive therapies which could prevent such injury and thereby achieve greater benefits than might be possible with timely reperfusion alone.
When and if reperfusion injury occurs, what mechanisms contribute to its development if it occurs, and whether adjunctive therapies, when applied just before or during the reperfusion phase will be of benefit, are intricately intertwined questions. The strongest supportive evidence for the existence of a particular mechanism of reperfusion injury is the demonstration that adjunctive therapy, which interrupts the proposed mechanism, attenuates the injury.
At least 3 major pathways are of interest as pos-tulated mechanisms oflethal reperfusion injury ( Fig.  3 ) (62). First, cellular acidosis could contribute to a calcium overload via sodium/hydrogen exchange and calcium/sodium exchange (43, 49) . A calcium overload is most likely the cause of myofibrillar hypercontraction and could contribute to rupture of the sarcolemma. Second, ischemia causes an intracellular osmotic load of accumulated catabolites which could cause substantial cell swelling when reperfusion provides an effectivelyunlimited supply of plasma water. This osmotic swelling, coupled with an already weakened membrane, could result in membrane rupture (35) . Third, purine bases and/or accumulating polymorphonuclear neutrophils (PMNs) are among several possible sources of free radicals, which may injure the sarcolemma (47) . The relative importance of these (and other possible) pathways in the pathogenesis of ischemic cell death has not been established. dence that free oxygen radicals cause cellular damage associated with carbon tetrachloride poisoning (59), paraquat poisoning (87) , and in experimental diabetes induced by alloxan (26) . In addition, free radicals generated by leukocytes contribute to killing of bacteria (83) and cause damage to the glomerular filter in certain forms of experimental glomerulonephritis (68) . Oxygen free radicals also have been implicated as a cause of tissue injury during reperfusion after cerebral and intestinal ischemia (18, 25, 56) , circulatory shock (55), organ transplantation (55), skin flap grafting (45) , and pulmonary hyperoxia (10) . In the last several years, the role of these reactive oxygen species in situations of myocardial ischemia and reperfusion has been studied extensively.
Evidence that Free Radicals Are Produced in Ischemic and/or Reperfused Myocardium
Electron spin resonance (ESR) spectroscopy has proven to be a good, although difficult, method to measure free radical production. With this technique, free radicals are detected directly in quickfrozen myocardium, or indirectly, using spin trap agents which react with the free radical to form stable adducts. Several such studies ofisolated perfused hearts, or intact dog hearts have shown that a "burst" offree radicals occurs immediately after reperfusion (2, 3, 22, 88) . There has been some controversy regarding the origin ofthe observed radicals and the possibility that some free radicals may be generated by the processing of tissue. Nevertheless, it appears that free radicals are produced and that most are derived from superoxide, because addition of superoxide dismutase has been shown to attenuate the "burst" (2, 89) .
Possible Sources ofFree Radicals in Ischemic and/or Reperfused Myocardium
The most important pathways through which free radicals may be formed, during either ischemia or reperfusion, have not been precisely defined. Many metabolic pathways are known to produce free radicals (19, 20) and several have been proposed to cause increased free radical production, especially during the initial phase of reperfusion: .O 2 -can be produced by the xanthine oxidase reaction, "leaky" mitochondrial respiration, catecholamine oxidation, metabolism of arachidonic acid, and the NADPH oxidase of activated neutrophils. Hydrogen peroxide may be produced from several sources, including xanthine oxidase, and .O 2 -via the superoxide dismutase reaction. The latter enzyme forms a normal defense mechanism of most aerobic cells. Accumulation of H 2 0 2 normally is prevented by catalase and peroxidases (such as glutathione per-oxidase), both ofwhich reduce H 2 0 2 to water. However, decreased activity of the latter enzymes (reported to occur in ischemic injury) combined with excess superoxide production, could overwhelm endogenous defenses. In this case, the hydroxyl radical may be produced as a product ofthe metal catalyzed reaction of .O 2 -with H 2 0 2 (Fenton reaction).
The 2 sources offree radicals which have received the most attention, from the aforementioned list of potential sources in reperfused myocardium, are the xanthine oxidase reaction and infiltrating neutrophils. The xanthine oxidase reaction produces .O 2and H 2 0 2 as a product of the oxidation of hypoxanthine to xanthine and/or xanthine to uric acid (47) . This pathway is a plausible source of superoxide in those species such as dogs, which have xanthine oxidase activity in the myocardium (8, 51) , because abundant quantities of hypoxanthine and its immediate precursor, inosine, accumulate in ischemic myocardium as a consequence of the degradation of adenine nucleotides (63) . On the other hand, this source offree radicals is an unlikely cause of lethal reperfusion injury in other species such as rabbits, pigs, or humans, in which xanthine oxidase activity is not detectable biochemically (12, 28, 51) .
Neutrophils in the reperfused tissue are another potential source offree radicals which have received widespread attention. It has long been recognized that neutrophils playa major role in the inflammatory response following myocardial infarction. In the absence of reperfusion, they can be detected within the infarct by histologic observation within 18-24 hr and are at peak concentration between 2 and 4 days after the onset of infarction. In successfully reperfused myocardium which has been irreversibly injured, neutrophils are seen in tissue sections shortly after the onset of reperfusion. In addition, quantitative studies with IIIIn-labeled neutrophils have shown substantial increases within 1 hr after reperfusion (14, 24, 48) .
Thus, although neutrophils participate in the digestion of dead myocytes, and, thereby, contribute to the healing process, they also are in a position to cause "reperfusion injury" during the early hours of reperfusion as well as later. Activated neutrophils produce the superoxide radical via the NADPH oxidase system, H 2 0 2 via dismutation of superoxide, and hypochlorous acid (household bleach) via the myeloperoxidase reaction. In addition, neutrophil granules contain a variety ofproteolytic and lipolytic enzymes (e.g., elastase, collagenase, acid hydrolases and phospholipase A 2 ) which can be released to the extracellular space (16) . Moreover, it has been shown that neutrophils may become trapped in capillaries and thereby impede reperfusion by simple mechanical obstruction to microvascular flow (15) .
Evaluating the Role ofFree Radicals in Lethal Reperfusion Injury
In order to prove or disprove a direct toxic effect of free radicals during reperfusion, it is necessary to determine whether interventions capable of reducing free radical concentration also limit infarct size followingischemic injury. Interventions which merit consideration in this regard have been reviewed recently (62) and include those which 1) prevent the production of free radicals from endogenous pathways, e.g., inhibitors of superoxide sources such as xanthine oxidase (allopurinol and oxypurinol) or hydroxyl radical production by the Fenton reaction (the iron chelator, desferrioxamine), 2) agents that "scavenge" free radicals, e.g., superoxide dismutase (with or without catalase) or N-2-mercaptopropionyl glycine (MPG), or 3) interventions that inhibit neutrophil function and/or accumulation in reperfused myocardium. The latter include depletion of circulating neutrophils using an anti-neutrophil antibody or extracorporeal filtration, antibody binding of specific neutrophil adhesion proteins (e.g., the anti-MO-l monoclonal antibody) and a variety of anti-inflammatory agents such as BW755C, prostacyclin, nafazatrom, iloprost, and ibuprofen. Indeed, there have been a substantial number of experimental studies of these various therapies, but the results have led to conflicting conclusions regarding efficacy.
Among the aforementioned agents, one of the most widely studied has been superoxide dismutase. A number of both positive and negative results have been reported from experimental animal studies from various laboratories in which the efficacy of superoxide dismutase (SOD) with or without catalase to limit myocardial infarct size has been tested (8, 21, 38, 46, 53, 54, 57, 58, 64, 71, 77, 80, 84, 85) .
The explanation for these discrepant results is unknown. Possible explanations include differences in 1) dose or manner of administration of therapeutic agent, 2) methods of evaluating the extent of injury produced, 3) animal species, and 4) experimental protocol including duration of occlusion, duration of reperfusion, and presence or absence of a critical coronary stenosis. We refer the reader to our recent review (62) for a detailed analysis of the major differences among the methods used among various studies. However, we have not identified an explanation or set of explanations which can account for all of the reported differences among results.
One of the recent hypotheses to explain the conflicting results was based on the observation that most of the studies demonstrating limitation of myocardial infarct size by native SOD have had an REIMERETAL TOXICOLOGIC PATHOLOGY In the treated dogs, 10,000 IV/kg of PEG-SOD and 55,000 units of catalase were administered during a 30 min period before reperfusion. There was an inverse relation between infarct size, expressed as a percentage of area at risk, and transmural collateral blood flow in controls. It is readily apparent that treatment with PEG-SOD and catalase did not alter this relation. This visual impression was confirmed by analysis ofcovariance (F = 1.14, p = NS). In addition, the same analysis, excluding 2 treated dogs which required defibrillation (arrows) did not change the conclusion (F = 1.44, P = NS). Reprinted with permission from Tanaka et al: eire. Res. 67: 636-644, 1990 (79) . experimental protocol in which infarcts were evaluated after a short period of reperfusion (less than 6 hr) (8, 53, 84) . Studies using protocols including longer reperfusion times (more than 3 days) usually have had negative results (54, 64, 80) . Thus, since the biological half life of SOD is very short (6-10 min), these discrepant results could be explained if myocytes, initially salvaged by SOD therapy, are killed later by continued production offree radicals after the administered SOD has been eliminated.
Infarct Size vs Collateral Blood Flow In Control and PEG -SOD
To test this hypothesis, we used polyethylene glycol-conjugated SOD (PEG-SOD), which prolonged the plasma halflife to 75 hr (79) . Nevertheless, PEG-SOD, like native SOD, failed to limit infarct size, as indicated by a similar relationship between infarct size and collateral flow in both groups (Fig. 4) . Thus, we again were unable to substantiate a causative role of superoxide radicals, accessible to circulating SOD, in cell death following ischemia and reperfusion in dogs. In contrast, Tamura et al (77) have reported positive results with a very low dose of PEG-SOD. Thus, the explanation for the many conflicting results among several laboratories remains unknown.
Role ofPolymorphonuclear Leukocytes (PMNs) in Lethal Reperfusion Injury
A number of ways have been devised to prevent the postulated detrimental role of PMNs in myocardium following ischemia and reperfusion. These include systemic depletion of circulating PMNs, using an anti-PMN antibody (39, 65, 72) or extracorporeal filtration (44) , and interference with neutrophil functions using various anti-inflammatory agents such as BW 755C (40, 48) , prostacyclin (74), nafazatrom (3, 70) , iloprost (72, 73) and ibuprofen (66) , and prevention of PMN accumulation in injured tissue by use of antibodies directed against glycoproteins which are expressed on the surface of activated PMNs and are responsible for PMN adhesion to endothelial cells (69) .
The adhesion-promoting glycoproteins consist of a family ofheterodimers, each of which has a common beta subunit designated CO 18,and one of three known alpha subunits designated CDlla (LFA-l), CDllb (Mol or Mac-1), and COlIc (gpI50) (69) . Monoclonal antibodies have been produced against one or more of the alpha subunits (e.g., anti-Mol (75» and against the common CDl8 subunit (e.g., MoAb 60.3 and IB 4 (1, 81) .
We recently reported (78) results ofa study which was done to determine whether treatment of dogs with a mouse monoclonal antibody (IB 4 ) against human PMN CD 18 would suppress PMN accumulation in injured myocardium following ischemia and reperfusion. In addition, we determined whether such treatment would prevent the microvascular leakiness to plasma proteins, improve myocardial perfusion following arterial reperfusion, and/or limit myocardial infarct size. Infarcts were produced by 90 min of circumflex coronary occlusion, followed by 3 hr of reperfusion in control and treated groups ofdogs. The treated animals received F(ab')2 fragments of the anti-CDl8 antibody both before occlusion and after reperfusion. PMN accumulation was measured using autologous 1I1In_ labeled PMNs, microvascular leakiness was measured with l25In-labeled albumin (RISA), collateral and post-ischemic myocardial blood flow was measured with tracer microspheres, and infarct size was measured with triphenyl tetrazolium chloride (TTC) macrochemistry.
The results were that anti-COl8 treatment markedly attenuated PMN accumulation following ischemia and reperfusion and improved post-ischemic myocardial perfusion but did not prevent microvascular leakiness to plasma proteins or limit myocardial infarct size.
CONCLUSIONS
There is now a substantial body of experimental evidence that free radicals are produced during reperfusion after an episode of ischemia. There also is evidence that free radicals, when generated in substantial quantities, can injure even non-ischemic myocytes and endothelial cells. In a setting of reversible injury, most studies have agreed that free radicals contribute in some way to post-ischemic contractile dysfunction (stunning).
Whether free radicals or other potentially detrimental aspects of neutrophil accumulation are an important cause of lethal myocyte injury is much less certain. A variety of interventions designed to scavenge or prevent the production of free radicals in reperfused myocardium, or to inhibit the influx or function ofneutrophils, per se, have been studied. Initially, most studies were positive, but a growing number of negative results have now been reported. Although a number of explanations for the conflicting results have been proposed, none seems capable of accounting for all of the reported differences. It seems likely that some ofthe conflicting results have occurred because of improper experimental design or analysis. Controversy regarding the efficacy ofan intervention on myocardial infarct size may be resolved in future studies, if baseline predictors of infarct size are adequately controlled and rigorous statistical analysis of the data is done.
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